• レポートコード:MRC2301E016 • 出版社/出版日:Persistence Market Research / 2022年10月3日 • レポート形態:英文、PDF、250ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Site Licence | ¥1,140,000 (USD7,600) | ▷ お問い合わせ |
Enterprisewide | ¥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査資料は、世界の代謝検査市場について総合的・多面的に調査しています。本資料では、エグゼクティブサマリー、市場概要、主要市場動向、ルール・規制、需要分析・予測、価格分析、市場背景、製品別(CPET装置、メタボリックカート、代謝量測定器、ECG・CPET装置取り付け型EKG(心電図)、ソフトウェア)分析、用途別(生活習慣病、クリティカルケア、ヒューマン・パフォーマンス・テスト、代謝不全症候群、その他)分析、技術別(VO2マックス分析、RMR分析、体組成分析)分析、エンドユーザー別(病院、研究所、スポーツトレーニングセンター、ジム、その他)分析、地域別(北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ)分析、構造分析、競争分析、仮定、調査方法などを整理しております。また、CareFusion Corporation、General Electric Company、Geratherm Medical AG、MGC Diagnostics Corporation、OSI Systems, Inc.、AEI Technologies, Inc.などの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・ルール・規制 ・需要分析・予測 ・価格分析 ・市場背景 ・世界の代謝検査市場規模:製品別 - CPET装置の市場規模 - メタボリックカートの市場規模 - 代謝量測定器の市場規模 - ECG・CPET装置取り付け型EKG(心電図)の市場規模 - ソフトウェアの市場規模 ・世界の代謝検査市場規模:用途別 - 生活習慣病における市場規模 - クリティカルケアにおける市場規模 - ヒューマン・パフォーマンス・テストにおける市場規模 - 代謝不全症候群における市場規模 - その他における市場規模 ・世界の代謝検査市場規模:技術別 - VO2マックス分析における市場規模 - RMR分析における市場規模 - 体組成分析における市場規模 ・世界の代謝検査市場規模:エンドユーザー別 - 病院における市場規模 - 研究所における市場規模 - スポーツトレーニングセンターにおける市場規模 - ジムにおける市場規模 - その他における市場規模 ・世界の代謝検査市場規模:地域別 - 北米の代謝検査市場規模 - 中南米の代謝検査市場規模 - ヨーロッパの代謝検査市場規模 - 東アジアの代謝検査市場規模 - 南アジアの代謝検査市場規模 - オセアニアの代謝検査市場規模 - 中東・アフリカの代謝検査市場規模 ・構造分析 ・競争分析 ・仮定 ・調査方法 |
Metabolic Testing Market: Report Scope
The latest market report by Persistence Market Research on the global metabolic testing market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2022-2032. The report provides a detailed assessment of key market dynamics and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2022-2032.
The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with metabolic testing. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to the compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.
This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on future trends in the market. Furthermore, new and emerging players in the global metabolic testing market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.
The study is relevant for manufacturers, suppliers, distributors, and investors in the metabolic testing market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.
Key Market Segments
Persistence Market Research’s report on the global metabolic testing market offers information divided into five segments – product, application, technology, end user, and region.
Product
CPET Systems
Metabolic Carts
Body Consumption Analyzers
ECGs/EKGs Attachable to CPET Systems
Software
Application
Lifestyle Diseases
Critical Care
Human Performance Testing
Dysmetabolic Syndrome X
Metabolic Disorders
Other Applications
Technology
VO2 Max Analysis
RMR Analysis
Body Composition Analysis
End User
Hospitals
Laboratories
Sports Training Centers
Gyms
Other End Users
Region
North America
Europe
Latin America
East Asia
The Middle East & Africa
South Asia & Pacific
Key Questions Answered in Study
Which region will hold the highest market share over the forecast period?
Which region is experiencing the highest growth (CAGR)?
Which factors are impacting the global metabolic testing industry?
What are the global trends impacting the market?
What strategies must emerge players adopt to capture opportunities in various regions in the market?
What is the structure of the global metabolic testing market?
Research Methodology
Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global metabolic testing market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.
A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period.
This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions – North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East & Africa, which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements.
Our main sources of research include:
Primary Research
Secondary Research
Trade Research
Social Media Research
1. Executive Summary
1.1. Global Market Overview
1.2. Summary of Key Statistics
1.3. Summary of Key Findings
1.4. Product Evolution Analysis
1.5. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Future Prospects of Metabolic Testing Industry
3.2.1. Factors Fuelling Growth
3.2.2. Influx of Brands
3.2.3. Innovative Distribution & Marketing Strategies
4. Rules and Regulations
4.1. Warning Labels
4.2. Regulatory Options for Little Cigars
4.2.1. Product Description
4.2.2. Health Risks
4.2.3. End Usering
4.2.4. Minimum Pack Technology Regulatory Gap
4.3. Cigar Labeling and Warning Statement Requirements by FDA
4.4. Tobacco Control Laws
4.4.1. Use of E-Cigarettes is Prohibited
4.4.2. Tobacco Advertising is Prohibited in Mass Media
4.4.3. Others
4.5. Others (During the Course of Study)
5. Global Metabolic Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032
5.1. Historical Market Volume (‘000 Units) Analysis, 2017-2021
5.2. Current and Future Market Volume (‘000 Units) Projections, 2022-2032
5.3. Y-o-Y Growth Trend Analysis
6. Global Metabolic Testing Market – Pricing Analysis
6.1. Pricing Analysis By Product
6.2. Global Average Pricing Analysis Benchmark
7. Global Metabolic Testing Market Demand (in Value or Technology in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Global Cigar industry Outlook
8.1.1. Perception of Cigars
8.1.2. Prevalence of Smoking Cigars among Adults
8.1.3. Top 10 Cigars & Cigarillo Companies in the World
8.2. Macro-Economic Factors
8.2.1. GDP Growth Outlook
8.2.2. Consumer Spending Outlook
8.2.3. GDP Growth Rate Analysis
8.2.4. Income Group Population Overview
8.2.5. Per Capita Disposable Income
8.3. Forecast Factors – Relevance & Impact
8.3.1. Top Companies Historical Growth
8.3.2. Urbanization Growth Outlook
8.3.3. Others
8.4. PESTLE Analysis of Global Metabolic Testing Market
8.5. Investment Feasibility Matrix of Metabolic Testing Market
8.6. Porter’s Five Forces Analysis of Global Metabolic Testing Market
8.7. Market Dynamics
8.7.1. Drivers
8.7.2. Restraints
8.7.3. Opportunity Analysis
9. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Product, 2017 – 2021
9.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Product, 2022 – 2032
9.3.1. CPET Systems
9.3.2. Metabolic Carts
9.3.3. Body Consumption Analyzers
9.3.4. ECGs/EKGs Attachable to CPET Systems
9.3.5. Software
9.4. Market Attractiveness Analysis by Product
10. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Application, 2017 – 2021
10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Application, 2022 – 2032
10.3.1. Lifestyle Diseases
10.3.2. Critical Care
10.3.3. Human Performance Testing
10.3.4. Dysmetabolic Syndrome X
10.3.5. Metabolic Disorders
10.3.6. Other Applications
10.4. Market Attractiveness Analysis by Application
11. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technology
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Technology, 2017 – 2021
11.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Technology, 2022 – 2032
11.3.1. VO2 Max Analysis
11.3.2. RMR Analysis
11.3.3. Body Composition Analysis
11.4. Market Attractiveness Analysis by Technology
12. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Flavor, 2017 – 2021
12.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Flavor, 2022 – 2032
12.3.1. Hospitals
12.3.2. Laboratories
12.3.3. Sports Training Centers
12.3.4. Gyms
12.3.5. Other End Users
12.4. Market Attractiveness Analysis by Flavor
13. Global Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis by Region, 2017 – 2021
13.3. Current Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast by Region, 2022 – 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis by Region
14. North America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product
14.4.3. By End User
14.4.4. By Application
14.4.5. By Technology
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End User
14.5.4. By Application
14.5.5. By Technology
15. Latin America Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Product
15.4.3. By End User
15.4.4. By Application
15.4.5. By Technology
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End User
15.5.4. By Application
15.5.5. By Technology
16. Europe Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. Rest of Europe
16.4.2. By Product
16.4.3. By End User
16.4.4. By Application
16.4.5. By Technology
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End User
16.5.4. By Application
16.5.5. By Technology
17. South Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Product
17.4.3. By End User
17.4.4. By Application
17.4.5. By Technology
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By End User
17.5.4. By Application
17.5.5. By Technology
18. East Asia Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Product
18.4.3. By End User
18.4.4. By Application
18.4.5. By Technology
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By End User
18.5.4. By Application
18.5.5. By Technology
19. Oceania Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product
19.4.3. By End User
19.4.4. By Application
19.4.5. By Technology
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By End User
19.5.4. By Application
19.5.5. By Technology
20. Middle East and Africa Metabolic Testing Market Analysis 2017-2021 and Forecast 2022-2032
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 – 2021
20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 – 2032
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Northern Africa
20.4.1.3. South Africa
20.4.1.4. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By End User
20.4.4. By Application
20.4.5. By Technology
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By End User
20.5.4. By Application
20.5.5. By Technology
21. Key Countries’ Metabolic Testing Market Analysis 2022-2032
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Metabolic Testing Market Analysis
21.2.1. By Product
21.2.2. By End User
21.2.3. By Application
21.2.4. By Technology
21.3. Canada Metabolic Testing Market Analysis
21.3.1. By Product
21.3.2. By End User
21.3.3. By Application
21.3.4. By Technology
21.4. Mexico Metabolic Testing Market Analysis
21.4.1. By Product
21.4.2. By End User
21.4.3. By Application
21.4.4. By Technology
21.5. Brazil Metabolic Testing Market Analysis
21.5.1. By Product
21.5.2. By End User
21.5.3. By Application
21.5.4. By Technology
21.6. Germany Metabolic Testing Market Analysis
21.6.1. By Product
21.6.2. By End User
21.6.3. By Application
21.6.4. By Technology
21.7. Italy Metabolic Testing Market Analysis
21.7.1. By Product
21.7.2. By End User
21.7.3. By Application
21.7.4. By Technology
21.8. U.K. Metabolic Testing Market Analysis
21.8.1. By Product
21.8.2. By End User
21.8.3. By Application
21.8.4. By Technology
21.9. China Metabolic Testing Market Analysis
21.9.1. By Product
21.9.2. By End User
21.9.3. By Application
21.9.4. By Technology
21.10. Japan Metabolic Testing Market Analysis
21.10.1. By Product
21.10.2. By End User
21.10.3. By Application
21.10.4. By Technology
21.11. S. Korea Metabolic Testing Market Analysis
21.11.1. By Product
21.11.2. By End User
21.11.3. By Application
21.11.4. By Technology
21.12. India Metabolic Testing Market Analysis
21.12.1. By Product
21.12.2. By End User
21.12.3. By Application
21.12.4. By Technology
21.13. Australia and New Zealand Metabolic Testing Market Analysis
21.13.1. By Product
21.13.2. By End User
21.13.3. By Application
21.13.4. By Technology
21.14. South Africa Metabolic Testing Market Analysis
21.14.1. By Product
21.14.2. By End User
21.14.3. By Application
21.14.4. By Technology
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies (Metabolic Testing)
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Regional footprint of Players
22.4.2. Product foot print by Players
22.4.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Pricing Analysis by Competition
23.3. Competition Benchmarking
23.4. Competition Deep Dive
23.4.1. CareFusion Corporation
23.4.1.1. Overview
23.4.1.2. Product Portfolio
23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
23.4.1.4. Sales Footprint
23.4.1.5. Strategy Overview
23.4.1.5.1. Marketing Strategy
23.4.1.5.2. Product Strategy
23.4.1.5.3. Channel Strategy
23.4.2. General Electric Company
23.4.2.1. Overview
23.4.2.2. Product Portfolio
23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
23.4.2.4. Sales Footprint
23.4.2.5. Strategy Overview
23.4.2.5.1. Marketing Strategy
23.4.2.5.2. Product Strategy
23.4.2.5.3. Channel Strategy
23.4.3. Geratherm Medical AG
23.4.3.1. Overview
23.4.3.2. Product Portfolio
23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
23.4.3.4. Sales Footprint
23.4.3.5. Strategy Overview
23.4.3.5.1. Marketing Strategy
23.4.3.5.2. Product Strategy
23.4.3.5.3. Channel Strategy
23.4.4. MGC Diagnostics Corporation
23.4.4.1. Overview
23.4.4.2. Product Portfolio
23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
23.4.4.4. Sales Footprint
23.4.4.5. Strategy Overview
23.4.4.5.1. Marketing Strategy
23.4.4.5.2. Product Strategy
23.4.4.5.3. Channel Strategy
23.4.5. OSI Systems, Inc.
23.4.5.1. Overview
23.4.5.2. Product Portfolio
23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
23.4.5.4. Sales Footprint
23.4.5.5. Strategy Overview
23.4.5.5.1. Marketing Strategy
23.4.5.5.2. Product Strategy
23.4.5.5.3. Channel Strategy
23.4.6. AEI Technologies, Inc.
23.4.6.1. Overview
23.4.6.2. Product Portfolio
23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
23.4.6.4. Sales Footprint
23.4.6.5. Strategy Overview
23.4.6.5.1. Marketing Strategy
23.4.6.5.2. Product Strategy
23.4.6.5.3. Channel Strategy
23.4.7. Cortex Biophysik GmbH
23.4.7.1. Overview
23.4.7.2. Product Portfolio
23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
23.4.7.4. Sales Footprint
23.4.7.5. Strategy Overview
23.4.7.5.1. Marketing Strategy
23.4.7.5.2. Product Strategy
23.4.7.5.3. Channel Strategy
23.4.8. COSMED
23.4.8.1. Overview
23.4.8.2. Product Portfolio
23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
23.4.8.4. Sales Footprint
23.4.8.5. Strategy Overview
23.4.8.5.1. Marketing Strategy
23.4.8.5.2. Product Strategy
23.4.8.5.3. Channel Strategy
23.4.9. Korr Medical Technologies, Inc.
23.4.9.1. Overview
23.4.9.2. Product Portfolio
23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
23.4.9.4. Sales Footprint
23.4.9.5. Strategy Overview
23.4.9.5.1. Marketing Strategy
23.4.9.5.2. Product Strategy
23.4.9.5.3. Channel Strategy
23.4.10. Microlife Medical Home Solutions, Inc.
23.4.10.1. Overview
23.4.10.2. Product Portfolio
23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
23.4.10.4. Sales Footprint
23.4.10.5. Strategy Overview
23.4.10.5.1. Marketing Strategy
23.4.10.5.2. Product Strategy
23.4.10.5.3. Channel Strategy
23.4.11. Parvo Medics, Inc.
23.4.11.1. Overview
23.4.11.2. Product Portfolio
23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
23.4.11.4. Sales Footprint
23.4.11.5. Strategy Overview
23.4.11.5.1. Marketing Strategy
23.4.11.5.2. Product Strategy
23.4.11.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology